Cargando…

Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations

Dravet syndrome is a genetic encephalopathy characterized by severe epilepsy combined with motor, cognitive, and behavioral abnormalities. Current antiepileptic drugs achieve only partial control of seizures and provide little benefit on the patient’s neurological development. In >80% of cases, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mora-Jimenez, Lucia, Valencia, Miguel, Sanchez-Carpintero, Rocio, Tønnesen, Jan, Fadila, Saja, Rubinstein, Moran, Gonzalez-Aparicio, Manuela, Bunuales, Maria, Fernandez-Pierola, Eva, Nicolas, Maria Jesus, Puerta, Elena, Miguelez, Cristina, Minguez, Paula Gimenez, Lumbreras, Sara, Gonzalez-Aseguinolaza, Gloria, Ricobaraza, Ana, Hernandez-Alcoceba, Ruben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463324/ https://www.ncbi.nlm.nih.gov/pubmed/34589280 http://dx.doi.org/10.1016/j.omtn.2021.08.003

Ejemplares similares

Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation
por: Ricobaraza, Ana, et al.
Publicado: (2019)

Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation
por: Ricobaraza, Ana, et al.
Publicado: (2021)

Viral vector–mediated expression of Na(V)1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome
por: Fadila, Saja, et al.
Publicado: (2023)

Gene supplementation of CYP27A1 in the liver restores bile acid metabolism in a mouse model of cerebrotendinous xanthomatosis
por: Lumbreras, Sara, et al.
Publicado: (2021)

Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis
por: Buñuales, Maria, et al.
Publicado: (2021)

Alterations of the Hippocampal Neurogenic Niche in a Mouse Model of Dravet Syndrome
por: Martín-Suárez, Soraya, et al.
Publicado: (2020)

High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy
por: Ricobaraza, Ana, et al.
Publicado: (2020)

Not all SCN1A epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotype
por: Sadleir, Lynette G., et al.
Publicado: (2017)

Beyond Dravet Syndrome: Characterization of a Novel, More Severe SCN1A-Linked Epileptic Encephalopathy
por: Beck, Veronica C., et al.
Publicado: (2019)

Danio Rerio as Model Organism for Adenoviral Vector Evaluation
por: Gulías, Paola, et al.
Publicado: (2019)

Dravet Syndrome: A Developmental and Epileptic Encephalopathy
por: Lopez-Santiago, Luis, et al.
Publicado: (2019)

Efficacy of Stiripentol in Dravet Syndrome with or without SCN1A Mutations
por: Cho, Min Jung, et al.
Publicado: (2018)

Dravet syndrome: a new causative SCN1A mutation?
por: Poryo, Martin, et al.
Publicado: (2017)

Drug repurposing for Dravet syndrome in scn1Lab (−/−) mutant zebrafish
por: Sourbron, Jo, et al.
Publicado: (2019)

Ictal vocalizations in the Scn1a (+/−) mouse model of Dravet syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2023)

Augmented Reticular Thalamic Bursting and Seizures in Scn1a-Dravet Syndrome
por: Ritter-Makinson, Stefanie, et al.
Publicado: (2019)

Augmented Reticular Thalamic Bursting and Seizures in Scn1a-Dravet Syndrome
por: Ritter-Makinson, Stefanie, et al.
Publicado: (2019)

Acute effect of antiseizure drugs on background oscillations in Scn1a (A1783V) Dravet syndrome mouse model
por: Quinn, Shir, et al.
Publicado: (2023)

Delayed maturation of GABAergic signaling in the Scn1a and Scn1b mouse models of Dravet Syndrome
por: Yuan, Yukun, et al.
Publicado: (2019)

Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome
por: Lenk, Guy M., et al.
Publicado: (2020)

Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
por: Nistal-Villan, Estanislao, et al.
Publicado: (2015)

Morphometry and network-based atrophy patterns in SCN1A-related Dravet syndrome
por: Lenge, Matteo, et al.
Publicado: (2023)

SCN1B and SCN2B gene variants analysis in dravet syndrome patients: Analysis of 22 cases
por: Gong, Jiao-E., et al.
Publicado: (2019)

Dravet Syndrome in Lebanon: First Report on Cases with SCN1A Mutations
por: Alame, Saada, et al.
Publicado: (2019)

TANGO With SCN1A: Can This Molecular Dance Defeat Dravet Syndrome?
por: Wagnon, Jacy L.
Publicado: (2020)

Heat-induced seizures, premature mortality, and hyperactivity in a novel Scn1a nonsense model for Dravet syndrome
por: Mavashov, Anat, et al.
Publicado: (2023)

Identification of SCN1A and PCDH19 Mutations in Chinese Children with Dravet Syndrome
por: Kwong, Anna Ka-Yee, et al.
Publicado: (2012)

A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and Signaling
por: Nistal-Villan, Estanislao, et al.
Publicado: (2016)

Dravet Variant SCN1A(A1783V) Impairs Interneuron Firing Predominantly by Altered Channel Activation
por: Layer, Nikolas, et al.
Publicado: (2021)

Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology
por: Catarino, Claudia B., et al.
Publicado: (2011)

SCN1A Gene Mutation and Adaptive Functioning in 18 Vietnamese Children with Dravet Syndrome
por: Do, Thi Thu Hang, et al.
Publicado: (2017)

Behavioral Comorbidities and Drug Treatments in a Zebrafish scn1lab Model of Dravet Syndrome
por: Grone, Brian P., et al.
Publicado: (2017)

SCN1A Mutation—Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis
por: Ding, Jiangwei, et al.
Publicado: (2021)

Multimodal Analysis of SCN1A Missense Variants Improves Interpretation of Clinically Relevant Variants in Dravet Syndrome
por: Gonsales, Marina C., et al.
Publicado: (2019)

SCN1A Genetic Test for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy and its Clinical Subtypes) for use in the Diagnosis, Prognosis, Treatment and Management of Dravet Syndrome
por: Stenhouse, Susan A.R., et al.
Publicado: (2013)

Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet Syndrome treatment
por: Baraban, Scott C., et al.
Publicado: (2013)

The dose makes the poison—Novel insights into Dravet syndrome and SCN1A regulation through nonproductive splicing
por: Helbig, Ingo, et al.
Publicado: (2021)

Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence
por: Sola-Sevilla, Noemi, et al.
Publicado: (2021)

The Role of Focal Epilepsy Features in Defining SCN1A Mutation-positive Dravet Syndrome as Generalized and Focal Epilepsy
por: Ko, Young Jun, et al.
Publicado: (2021)

Novel SCN1A and GABRA1 Gene Mutations With Diverse Phenotypic Features and the Question on the Existence of a Broader Spectrum of Dravet Syndrome
por: Gontika, Maria P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ouvk15evo9dopbo2g7ls8f9mlm